PT - JOURNAL ARTICLE AU - Wiley, Laura K AU - Shortt, Jonathan A AU - Roberts, Emily R AU - Lowery, Jan AU - Kudron, Elizabeth AU - Lin, Meng AU - Mayer, David A AU - Wilson, Melissa P AU - Brunetti, Tonya M AU - Chavan, Sameer AU - Phang, Tzu L AU - Pozdeyev, Nikita AU - Lesny, Joseph AU - Wicks, Stephen J AU - Moore, Ethan AU - Morgenstern, Joshua L AU - Roff, Alanna N AU - Shalowitz, Elise L AU - Stewart, Adrian AU - Williams, Cole AU - Edelmann, Michelle N AU - Hull, Madelyne AU - Patton, J. Tacker AU - Axell, Lisen AU - Ku, Lisa AU - Lee, Yee Ming AU - Jirikowic, Jean AU - Tanaka, Anna AU - Todd, Emily AU - White, Sarah AU - Peterson, Brett AU - Hearst, Emily AU - Zane, Richard AU - Greene, Casey S AU - Mathias, Rasika AU - Coors, Marilyn AU - Taylor, Matthew RG AU - Kahn, Michael G AU - Brooks, Ian M AU - Aquilante, Christina L AU - Kao, David AU - Rafaels, Nicholas AU - Crooks, Kristy AU - Hess, Steve AU - Barnes, Kathleen C AU - Gignoux, Christopher R AU - the Colorado Center for Personalized Medicine TI - Building a Vertically-Integrated Genomic Learning Health System: The Colorado Center for Personalized Medicine Biobank AID - 10.1101/2022.06.09.22276222 DP - 2022 Jan 01 TA - medRxiv PG - 2022.06.09.22276222 4099 - http://medrxiv.org/content/early/2022/06/14/2022.06.09.22276222.short 4100 - http://medrxiv.org/content/early/2022/06/14/2022.06.09.22276222.full AB - Precision medicine initiatives across the globe have led to a revolution of repositories linking large-scale genomic data with electronic health records, enabling genomic analyses across the entire phenome. Many of these initiatives focus solely on research insights, leading to limited direct benefit to patients. We describe the Biobank at the Colorado Center for Personalized Medicine (CCPM Biobank) that was jointly developed by the University of Colorado Anschutz Medical Campus and UCHealth to serve as a unique, dual-purpose research and clinical resource accelerating personalized medicine. This living resource currently has over 200,000 patients with ongoing recruitment. We highlight the clinical, laboratory, regulatory, and HIPAA-compliant informatics infrastructure along with our stakeholder engagement, consent, recontact, and participant engagement strategies. We characterize aspects of genetic and geographic diversity unique to the Rocky Mountain Region, the primary catchment area for CCPM Biobank participants. We leverage linked health and demographic information of the CCPM Biobank participant population to demonstrate the utility of the CCPM Biobank to replicate complex trait associations in the first 33,674 genotyped patients across multiple disease domains. Finally, we describe our current efforts towards return of clinical genetic test results including high-impact pathogenic variants and pharmacogenetic information, and our broader goals as the CCPM Biobank continues to grow. Bringing clinical and research interests together fosters unique clinical and translational questions that can be addressed from the large EHR-linked CCPM Biobank resource within a HIPAA and CLIA-certified environment.Competing Interest StatementKCB owns stock in, and is a part-time employee of Tempus. CRG owns stock in 23andMe, Inc. All other authors declare no relevant conflicts of interest. Funding StatementML and CRG were partially supported by the National Institutes of Health (R01HL151152, R01HG011345, and U01HG011715). KCB was partially supported by the Department Endowed Chair of Medicine, National Institutes of Health (R01AI132476, R01HL104608, R25HL146166, 5UM1AI109565-07, 5U19 AI117673-05) and Regeneron Pharmaceuticals, Inc. (Project #4841-4450-1168.2). LKW was partially supported by the National Institutes of Health (K01LM013088). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Colorado Multiple Institutional Review Board (COMIRB) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.